| Open Document File Size: 74,75 KBShare Result on Facebook
Company Novartis / / Event FDA Phase / / IndustryTerm appropriate inhalation device / healthcare practitioners / healthcare providers / inhalation device / / MedicalCondition COPD / exercise-induced bronchospasm / chronic obstructive pulmonary disease / asthma / / Organization Food & Drug Administration / office of Drug Safety / Division of Medication Errors and Technical Support / / Person Tina Tezky / Tina M. Tezky / Carol Holquist / / / Position Counsel / Safety Evaluator / •Counsel / Director / / Product Spiriva / beta-2 / HandiHaler capsules / Foradil / HandiHaler / / Technology drug delivery / / URL www.drugtopics.com / /
SocialTag |
Safety Page Misadministration of capsules for inhalation The Food & Drug Administration would like to alert healthcare providers to errors involving the inadvertent oral administration of Foradil Aerolizer and Spiriva Ha